Skip to main content
. 2016 Aug 24;39(11):684–691. doi: 10.1002/clc.22581

Table 1.

Randomized Trials Comparing Provisional Strategy and Complex Strategy for Coronary Bifurcation Lesions

Study Authors and Year Comparison Size MACE % PS/CS CV Death % PS/CS MI % PS/CS TVR % PS/CS MV Restenosis % PS/CS SB Restenosis % PS/CS
Colombo 200410 CS vs PS 85 N/A 0/1.6, P = NS 9/11.1, P = NS 9/11.1, P = NS 4.8/5.7, P = NS 14.2/21.8, P = NS
Pan 20049 CS vs PS 91 6.4/6.4 0/1.0 4/0 2/5 2/5 5/10
NORDIC; Steigen 20061 Crush, culotte, Y vs PS 413 2.9/3.4 1.0/1.0, P = 1.00 0/0.5, P = 0.31 1.9/1.9, P = 0.99 4.6/5.1, P = 0.84 19.2/11.5, P = 0.062
CACTUS; Colombo 20093 Crush vs PS 350 15.0/15.8, P = 0.95 0/0.5, P = 0.49 8.6/10.7, P = 0.59 7.5/7.9, P = 1.00 6.7/4.6, P > 0.05 14.7/13.2, P > 0.05
BBK; Ferenc 200811 T stenting vs PS 202 12.9/11.9, P = 0.83 2.0/1.0, P = 1.00 1/2, P = 1.00 N/A 7.3/3.1, P = 0.17 9.4/12.5, P = 0.32
Lin 201013 DK crush, culotte, T vs PS 108 11.1/38.9, P < 0.01 1.9/0, P = 1.00 1.9/1.9, P = 0.48 29.6/7.4, P < 0.01 14.8/9.3, P = 0.38 35.2/14.8, P = 0.015
BBC‐ONE; Hildick‐Smith 20104 Crush, culotte, T vs PS 500 8.0/15.2, P = 0.009 0.4/0.8 3.6/11.2, P = 0.001 5.6/7.2, P = 0.43 N/A N/A
DKCRUSH II; Chen 200116 DK crush vs PS 390 17.3/10.3, P = 0.07 1.1/1.1, P = 1.00 2.2/3.2, P = 0.751 14.6/6.5, P = 0.017 9.7/3.8, P = 0.036 22.2/4.9, P < 0.001
NORDIC Baltic IV; Kumsars 2013 CS vs PS 450 12.9/8.3, P = 0.12 0/0 1.8/0.9, P = 0.5 3.7/1.3, P = 0.11 2.6/2, P = NS 20.3/5.2, P < 0.001
PERFECT; Kim 201512 Crush vs PS 419 18.5/17.8, P = 0.85 0.5/0.9 P = 0.58 14.1/14.1, P = 0.98 3.4/2.9, P = 0.73 4.8/5.2, P = 0.90 8.3/3.9, P = 0.12

Abbreviations: BBC‐ONE, British Bifurcation Coronary Study: Old, New and Evolving Strategies; BBK, Bifurcations Bad Krozingen; CACTUS, Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus‐Eluting Stents; CS, complex strategy; CV, cardiovascular; DK, double kissing; DKCRUSH, Double Kissing Crush vs Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions; MACE, major adverse cardiovascular events; MI, myocardial infarction; MV, main vessel; NORDIC, Nordic Bifurcation Stent Technique Study; NS, not significant; PERFECT, Optimal Stenting Strategy for True Bifurcation Lesions; PS, provisional strategy; SB, side branch; TVR, target‐vessel revascularization.